Behrman Capital-backed The Emmes Company LLC has acquired clinical research organization Neox S.R.O. The purchase expands Emmes’ biopharma effort and European presence.
“As Emmes’ first add-on acquisition, Neox expands Emmes’ international presence, notably in Central Europe, by adding significant strategic capabilities to enhance the company’s BioPharma effort. Neox will serve as a launch pad for Emmes in Europe to begin offering CRO services to BioPharma clients that require EU-based trials.” says Behrman managing partner Grant Behrman.
Clinical research organization Emmes is focused on growing its biopharma and public sector business groups. Neox will be part of Emmes BioPharma, which also includes Emmes’ established, experienced teams in the USA, India and Canada.